80
Sampaio WO, Henrique de Castro C, Santos RA, Schiffrin EL, Touyz RM.
Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial
cells. Hypertension. 50:1093-8, 2007.
Santos RAS, Brum JM, Brosnihan KB, Ferrario CM: The renin angiotensin system
during acute myocardial ischemia in dogs. Hypertension 15(Suppl. 2): I121-I127,
1990.
Santos RAS, Campagnole-Santos MJ, Baracho NCV, Fontes MAP, Silva LCS, Neves
LAA, Oliveira DR, Caligiorne SM, Rodrigues ARV, Gropen C Jr, Carvalho WS,
Simoes E, Silva AC, and Khosla MC. Characterization of a new angiotensin
antagonist selective for angiotensin- (1–7): evidence that the actions of angiotensin-
(1–7) are mediated by specific angiotensin receptors. Brain Res Bull. 35: 293–298,
1994.
Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de B, I, Heringer-
Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-
Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous
ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100:8258-
63, 2003.
Santos RAS, Ferreira AJ, Nadu AP, Braga ANG, Almeida AP, Campagnole-Santos
MJ, Baltatu O, Iliescu R, Reudelhuber TL and Bader M. Expression of an
angiotensin-(1–7) producing fusion protein produces cardioprotective effects in rats.
Physiol Genomics 17:292– 9, 2004.
Santos RA, Frezard F, Ferreira AJ. Angiotensin-(1-7): blood, heart, and blood
vessels. Curr Med Chem Cardiovasc Hematol Agents 3:383-91, 2005.
Santos RA, Castro CH, Gava E, Pinheiro SV, Almeida AP, Paula RD, Cruz JS,
Ramos AS, Rosa KT, Irigoyen MC, Bader M, Alenina N, Kitten GT, Ferreira AJ.
Impairment of in vitro and in vivo heart function in angiotensin-(1-7) receptor MAS
knockout mice. Hypertension 47: 996-1002, 2006.
Santos RA, Ferreia AJ, Simões e Silva AC. Recent advances in the angiotensin-
converting enzyme 2_angiotensin(1_7)_Mas axis. Exp Physiol 93: 519-527, 2008.
Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC & Ferrario CM. Release of
vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1–7)
heptapeptide. Proc Natl Acad Sci 4095–4098, 1988.
Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat
cardiac angiotensin-converting enzyme activity and mRNA levels in pressure
overload left ventricular hypertrophy. J Clin Invest 86:1913–1920, 1990.
Seddon M, Ajay M. Shah, Barbara Casadei. Cardiomyocytes as effectors of nitric
oxide signaling. Cardiovasc Res. 75:315-26, 2007.
Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price Jr E, Roberts RL. A novel
angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy.
EMBO J
. 22: 6471– 82, 2003.